Jeff Yass’s Scribe Therapeutics SCTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$251K Buy
+13,641
New +$360K ﹤0.01% 11387

Other funds holding SCTX

Jeff Yass's SCTX Position: Q3 2026 in Review

Jeff Yass opened a new position in Scribe Therapeutics (SCTX) in Q3 2026: 13,641 shares worth $251K. The stake represents ﹤0.01% of the portfolio and ranks #11387 among its holdings.

62 funds tracked by Wall St. Rank hold SCTX as of Q3 2026.

  • Jeff Yass held 13,641 shares of Scribe Therapeutics worth $251K as of Q3 2026.
  • Scribe Therapeutics was a new Jeff Yass position in Q3 2026.
  • Scribe Therapeutics made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #11387 holding.
  • 62 funds tracked by Wall St. Rank held Scribe Therapeutics as of Q3 2026.

Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.